Search research articles
Contact Us
Filters
Showing results (31-40 of 147) with videos related to
Page
of 15
Sort By:
Journal of Hematology & Oncology
|
January 14, 2018
Cancer immunotherapy beyond immune checkpoint inhibitors
Julian A Marin-Acevedo, Aixa E Soyano, Bhagirathbhai Dholaria, et al.
Critical Reviews in Immunology
|
April 16, 2013
The immune system in the pathogenesis of ovarian cancer
Bridget Charbonneau, Ellen L Goode, Kimberly R Kalli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 28, 2012
Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells
Andrea M Henle, Courtney L Erskine, Linda M Benson, et al.
Cancers
|
May 27, 2026
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation
Panuch Eiamprapaporn, Cindy Venegas Mata, Raj Nandani, et al.
Breast Cancer Research and Treatment
|
November 10, 2009
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
Johanna K Morales, Maciej Kmieciak, Keith L Knutson, et al.
Immunotherapy
|
April 6, 2011
Immunity and immune suppression in human ovarian cancer
Claudia C Preston, Ellen L Goode, Lynn C Hartmann, et al.
Cancer Research
|
May 11, 2011
TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype
Michael K Asiedu, James N Ingle, Marshall D Behrens, et al.
Journal of Hematology & Oncology
|
March 17, 2018
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A Marin-Acevedo, Bhagirathbhai Dholaria, Aixa E Soyano, et al.
Research Square
|
April 22, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma
Emmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Scientific Reports
|
October 19, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma
Emmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 147) with videos related to
Sort By:
Page
of 15
Journal of Hematology & Oncology
|
January 14, 2018
Cancer immunotherapy beyond immune checkpoint inhibitors
Julian A Marin-Acevedo, Aixa E Soyano, Bhagirathbhai Dholaria, et al.
Critical Reviews in Immunology
|
April 16, 2013
The immune system in the pathogenesis of ovarian cancer
Bridget Charbonneau, Ellen L Goode, Kimberly R Kalli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 28, 2012
Enzymatic discovery of a HER-2/neu epitope that generates cross-reactive T cells
Andrea M Henle, Courtney L Erskine, Linda M Benson, et al.
Cancers
|
May 27, 2026
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation
Panuch Eiamprapaporn, Cindy Venegas Mata, Raj Nandani, et al.
Breast Cancer Research and Treatment
|
November 10, 2009
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
Johanna K Morales, Maciej Kmieciak, Keith L Knutson, et al.
Immunotherapy
|
April 6, 2011
Immunity and immune suppression in human ovarian cancer
Claudia C Preston, Ellen L Goode, Lynn C Hartmann, et al.
Cancer Research
|
May 11, 2011
TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype
Michael K Asiedu, James N Ingle, Marshall D Behrens, et al.
Journal of Hematology & Oncology
|
March 17, 2018
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A Marin-Acevedo, Bhagirathbhai Dholaria, Aixa E Soyano, et al.
Research Square
|
April 22, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma
Emmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Scientific Reports
|
October 19, 2024
Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma
Emmanuel M Gabriel, Brian Necela, Deborah Bahr, et al.
Page
of 15